FDA NDC Directory · JSON-LD · Markdown

acamprosate calcium

NDC 68382-569 · HUMAN PRESCRIPTION DRUG · TABLET, DELAYED RELEASE

Labeler / ManufacturerZydus Pharmaceuticals (USA) Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA205995
Dosage form / routeTABLET, DELAYED RELEASE · ORAL
Active ingredientsACAMPROSATE CALCIUM (333 mg/1)
Marketing started20170601
Package count6

External sources

Source: openFDA. Public-domain (CC0).